12,123 followers
RT @FrontOncology: New research: Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastat…
RT @FrontOncology: New research: Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastat…
New research: Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors: Background This study aimed… https://t.c